12/17/2024 3:02 PM | Protara Therapeutics, Inc. (Subject) Protara Therapeutics (Subject) Velan Capital Investment Management LP (Filed by)
| Form SC 13G | |
12/11/2024 3:19 PM | Protara Therapeutics, Inc. (Filer) Protara Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/11/2024 6:30 AM | Protara Therapeutics, Inc. (Filer) Protara Therapeutics (Filer)
| Form 424B5 | |
12/09/2024 3:17 PM | Protara Therapeutics, Inc. (Filer) Protara Therapeutics (Filer)
| Form 424B5 | |
12/05/2024 7:45 AM | Protara Therapeutics, Inc. (Filer) Protara Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/18/2024 5:01 AM | Opaleye Management Inc. (Filed by) Protara Therapeutics, Inc. (Subject) Protara Therapeutics (Subject)
| Form SC 13G | |
11/14/2024 11:19 AM | CVI Investments, Inc. (Filed by) Protara Therapeutics, Inc. (Subject) Protara Therapeutics (Subject)
| Form SC 13G/A | |
|
09/12/2024 7:20 PM | Opaleye Management Inc. (Reporting) Protara Therapeutics, Inc. (Issuer) Protara Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/10/2024 6:11 PM | Opaleye Management Inc. (Reporting) Protara Therapeutics, Inc. (Issuer) Protara Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/30/2024 3:05 PM | Protara Therapeutics, Inc. (Issuer) Protara Therapeutics (Issuer) Shefferman Jesse (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/06/2024 3:16 PM | Protara Therapeutics, Inc. (Filer) Protara Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
07/18/2024 3:05 PM | Opaleye Management Inc. (Reporting) Protara Therapeutics, Inc. (Issuer) Protara Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/11/2024 6:56 PM | Opaleye Management Inc. (Reporting) Protara Therapeutics, Inc. (Issuer) Protara Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2024 1:00 PM | Opaleye Management Inc. (Reporting) Protara Therapeutics, Inc. (Issuer) Protara Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2024 5:45 PM | Opaleye Management Inc. (Reporting) Protara Therapeutics, Inc. (Issuer) Protara Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 5:00 PM | BESHAR LUKE M (Reporting) Protara Therapeutics, Inc. (Issuer) Protara Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 5:00 PM | GARCEAU ROGER (Reporting) Protara Therapeutics, Inc. (Issuer) Protara Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 5:00 PM | Huang Jane (Reporting) Protara Therapeutics, Inc. (Issuer) Protara Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 5:00 PM | Levy Richard S (Reporting) Protara Therapeutics, Inc. (Issuer) Protara Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 5:00 PM | Protara Therapeutics, Inc. (Issuer) Protara Therapeutics (Issuer) SARGEN GREGORY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 5:00 PM | Protara Therapeutics, Inc. (Issuer) Protara Therapeutics (Issuer) Solomon Michael Edward (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 5:00 PM | Protara Therapeutics, Inc. (Issuer) Protara Therapeutics (Issuer) Smith Cynthia (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 5:00 PM | Flannelly Barry P (Reporting) Protara Therapeutics, Inc. (Issuer) Protara Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/23/2024 6:01 PM | Opaleye Management Inc. (Reporting) Protara Therapeutics, Inc. (Issuer) Protara Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/17/2024 6:48 PM | Opaleye Management Inc. (Reporting) Protara Therapeutics, Inc. (Issuer) Protara Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/10/2024 5:57 PM | Opaleye Management Inc. (Reporting) Protara Therapeutics, Inc. (Issuer) Protara Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/09/2024 11:15 PM | Protara Therapeutics, Inc. (Filer) Protara Therapeutics (Filer)
| Form EFFECT | |
05/02/2024 3:16 PM | Protara Therapeutics, Inc. (Filer) Protara Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
05/02/2024 7:05 AM | Protara Therapeutics, Inc. (Filer) Protara Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/02/2024 7:10 AM | Protara Therapeutics, Inc. (Filer) Protara Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/25/2024 7:43 PM | Protara Therapeutics, Inc. (Subject) Protara Therapeutics (Subject) RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G | |
04/09/2024 9:43 AM | CVI Investments, Inc. (Filed by) Protara Therapeutics, Inc. (Subject) Protara Therapeutics (Subject)
| Form SC 13G | |
04/05/2024 7:14 AM | Protara Therapeutics, Inc. (Filer) Protara Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/18/2024 4:17 PM | Protara Therapeutics, Inc. (Filer) Protara Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/13/2024 7:05 AM | Protara Therapeutics, Inc. (Filer) Protara Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/13/2024 7:10 AM | Protara Therapeutics, Inc. (Filer) Protara Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/14/2024 6:11 PM | ORBIMED ADVISORS LLC (Filed by) Protara Therapeutics, Inc. (Subject) Protara Therapeutics (Subject)
| Form SC 13G/A | |
01/23/2024 3:05 PM | Fry Hannah (Reporting) Protara Therapeutics, Inc. (Issuer) Protara Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/23/2024 3:05 PM | Fabbio Patrick (Reporting) Protara Therapeutics, Inc. (Issuer) Protara Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/23/2024 3:05 PM | Protara Therapeutics, Inc. (Issuer) Protara Therapeutics (Issuer) Zummo Jacqueline (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/23/2024 3:05 PM | Bandari Jathin (Reporting) Protara Therapeutics, Inc. (Issuer) Protara Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
Did You See Trump’s Bombshell Exec. Order 001? (Ad) Biden broke it... Now Trump is going to fix it.
Starting with "Exec. Order 001." I put all the details together for you here — but please hurry. |
01/23/2024 3:05 PM | Protara Therapeutics, Inc. (Issuer) Protara Therapeutics (Issuer) Shefferman Jesse (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/12/2024 3:05 PM | Bandari Jathin (Reporting) Protara Therapeutics, Inc. (Issuer) Protara Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/12/2024 3:05 PM | Protara Therapeutics, Inc. (Issuer) Protara Therapeutics (Issuer) Zummo Jacqueline (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/12/2024 3:05 PM | Protara Therapeutics, Inc. (Issuer) Protara Therapeutics (Issuer) Shefferman Jesse (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2024 3:30 PM | Protara Therapeutics, Inc. (Issuer) Protara Therapeutics (Issuer) Shefferman Jesse (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2024 3:35 PM | Protara Therapeutics, Inc. (Issuer) Protara Therapeutics (Issuer) Zummo Jacqueline (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |